JAK / Stat

产品 201 到 209 共 209个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置升序顺序
  1. Tarloxotinib bromide

    Catalog No. A20849
    Quick View
    EGFR/HER2 inhibitor
    Tarloxotinib bromide (TH-4000) is an irreversible EGFR/HER2 inhibitor. 了解更多
  2. Mutant EGFR inhibitor

    Catalog No. A21144
    Quick View
    EGFR inhibitor
    Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. 了解更多
  3. HS-10296 hydrochloride

    Catalog No. A21661
    Quick View
    EGFR/T790M inhibitor
    HS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多
  4. AST2818 mesylate

    Catalog No. A21666
    Quick View
    EGFR inhibitor
    AST2818 mesylate is an EGFR inhibitor. 了解更多
  5. Nazartinib mesylate

    Catalog No. A21741
    Quick View
    covalent mutant-selective EGFR inhibitor
    Nazartinib mesylate (EGF816 mesylate) is a novel, covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0.222 min?1 on EGFR(L858R/790M) mutant, respectively. 了解更多
  6. Nazartinib S-enantiomer

    Catalog No. A21747
    Quick View
    EGFR inhibitor
    Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor. 了解更多
  7. Pyrotinib dimaleate

    Catalog No. A21756
    Quick View
    EGFR/HER2 dual inhibitor
    Pyrotinib dimaleate (SHR-1258 dimaleate) is a potent and selective EGFR/HER2 dual inhibitor with IC50 s of 13 and 38 nM, respectively. 了解更多
  8. Epertinib hydrochloride

    Catalog No. A21950
    Quick View
    EGFR, HER2 and HER4 inhibitor
    Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  9. Lifirafenib

    Catalog No. A20988
    Quick View
    Raf/EGFR inhibitor
    Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. 了解更多

产品 201 到 209 共 209个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置升序顺序
Rewards